Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9346893rdf:typepubmed:Citationlld:pubmed
pubmed-article:9346893lifeskim:mentionsumls-concept:C0031330lld:lifeskim
pubmed-article:9346893lifeskim:mentionsumls-concept:C0521390lld:lifeskim
pubmed-article:9346893lifeskim:mentionsumls-concept:C0040549lld:lifeskim
pubmed-article:9346893lifeskim:mentionsumls-concept:C0814023lld:lifeskim
pubmed-article:9346893lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:9346893lifeskim:mentionsumls-concept:C0439855lld:lifeskim
pubmed-article:9346893lifeskim:mentionsumls-concept:C1879748lld:lifeskim
pubmed-article:9346893lifeskim:mentionsumls-concept:C1706853lld:lifeskim
pubmed-article:9346893lifeskim:mentionsumls-concept:C1711351lld:lifeskim
pubmed-article:9346893lifeskim:mentionsumls-concept:C1527178lld:lifeskim
pubmed-article:9346893pubmed:issue44lld:pubmed
pubmed-article:9346893pubmed:dateCreated1997-12-9lld:pubmed
pubmed-article:9346893pubmed:abstractTextNeurons require specific patterns of K+ channel subunit expression as well as the precise coassembly of channel subunits into heterotetrameric structures for proper integration and transmission of electrical signals. In vivo subunit coassembly was investigated by studying the pharmacological profile, distribution, and subunit composition of voltage-gated Shaker family K+ (Kv1) channels in rat cerebellum that are labeled by 125I-margatoxin (125I-MgTX; Kd, 0.08 pM). High-resolution receptor autoradiography showed spatial receptor expression mainly in basket cell terminals (52% of all cerebellar sites) and the molecular layer (39% of sites). Sequence-directed antibodies indicated overlapping expression of Kv1. 1 and Kv1.2 in basket cell terminals, whereas the molecular layer expressed Kv1.1, Kv1.2, Kv1.3, and Kv1.6 proteins. Immunoprecipitation experiments revealed that all 125I-MgTX receptors contain at least one Kv1.2 subunit and that 83% of these receptors are heterotetramers of Kv1.1 and Kv1.2 subunits. Moreover, 33% of these Kv1.1/Kv1.2-containing receptors possess either an additional Kv1.3 or Kv1.6 subunit. Only a minority of the 125I-MgTX receptors (<20%) seem to be homotetrameric Kv1.2 channels. Heterologous coexpression of Kv1.1 and Kv1.2 subunits in COS-1 cells leads to the formation of a complex that combines the pharmacological profile of both parent subunits, reconstituting the native MgTX receptor phenotype. Subunit assembly provides the structural basis for toxin binding pharmacology and can lead to the association of as many as three distinct channel subunits to form functional K+ channels in vivo.lld:pubmed
pubmed-article:9346893pubmed:languageenglld:pubmed
pubmed-article:9346893pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346893pubmed:citationSubsetIMlld:pubmed
pubmed-article:9346893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9346893pubmed:statusMEDLINElld:pubmed
pubmed-article:9346893pubmed:monthOctlld:pubmed
pubmed-article:9346893pubmed:issn0021-9258lld:pubmed
pubmed-article:9346893pubmed:authorpubmed-author:KaczorowskiG...lld:pubmed
pubmed-article:9346893pubmed:authorpubmed-author:SchwarzerCClld:pubmed
pubmed-article:9346893pubmed:authorpubmed-author:GarciaM LMLlld:pubmed
pubmed-article:9346893pubmed:authorpubmed-author:SlaughterR...lld:pubmed
pubmed-article:9346893pubmed:authorpubmed-author:KnausH GHGlld:pubmed
pubmed-article:9346893pubmed:authorpubmed-author:HannerMMlld:pubmed
pubmed-article:9346893pubmed:authorpubmed-author:KochR OROlld:pubmed
pubmed-article:9346893pubmed:authorpubmed-author:KoschakAAlld:pubmed
pubmed-article:9346893pubmed:authorpubmed-author:WannerS GSGlld:pubmed
pubmed-article:9346893pubmed:issnTypePrintlld:pubmed
pubmed-article:9346893pubmed:day31lld:pubmed
pubmed-article:9346893pubmed:volume272lld:pubmed
pubmed-article:9346893pubmed:ownerNLMlld:pubmed
pubmed-article:9346893pubmed:authorsCompleteYlld:pubmed
pubmed-article:9346893pubmed:pagination27577-81lld:pubmed
pubmed-article:9346893pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9346893pubmed:meshHeadingpubmed-meshheading:9346893-...lld:pubmed
pubmed-article:9346893pubmed:meshHeadingpubmed-meshheading:9346893-...lld:pubmed
pubmed-article:9346893pubmed:meshHeadingpubmed-meshheading:9346893-...lld:pubmed
pubmed-article:9346893pubmed:meshHeadingpubmed-meshheading:9346893-...lld:pubmed
pubmed-article:9346893pubmed:meshHeadingpubmed-meshheading:9346893-...lld:pubmed
pubmed-article:9346893pubmed:meshHeadingpubmed-meshheading:9346893-...lld:pubmed
pubmed-article:9346893pubmed:meshHeadingpubmed-meshheading:9346893-...lld:pubmed
pubmed-article:9346893pubmed:meshHeadingpubmed-meshheading:9346893-...lld:pubmed
pubmed-article:9346893pubmed:meshHeadingpubmed-meshheading:9346893-...lld:pubmed
pubmed-article:9346893pubmed:meshHeadingpubmed-meshheading:9346893-...lld:pubmed
pubmed-article:9346893pubmed:meshHeadingpubmed-meshheading:9346893-...lld:pubmed
pubmed-article:9346893pubmed:meshHeadingpubmed-meshheading:9346893-...lld:pubmed
pubmed-article:9346893pubmed:meshHeadingpubmed-meshheading:9346893-...lld:pubmed
pubmed-article:9346893pubmed:year1997lld:pubmed
pubmed-article:9346893pubmed:articleTitleComplex subunit assembly of neuronal voltage-gated K+ channels. Basis for high-affinity toxin interactions and pharmacology.lld:pubmed
pubmed-article:9346893pubmed:affiliationInstitute for Biochemical Pharmacology, Neuropharmacology Unit, University Innsbruck, Peter-Mayr Strasse 1, A-6020 Innsbruck, Austria.lld:pubmed
pubmed-article:9346893pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9346893pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9346893lld:pubmed